flecainide has been researched along with Dyspnea in 5 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of acute respiratory distress associated with a histological pattern of acute fibrinous and organizing pneumonia, and discuss the possible responsibility of flecainide therapy." | 4.12 | Flecainide-induced pneumonitis: a case report. ( Boland, L; Hantson, P; Haufroid, V; Hoton, D; Moureau, G; Saint-Marcoux, F; Zarrouk, E, 2022) |
| "Residue G1306 Neonatal laryngospasm and unusual distribution of myotonia, muscle hypertrophy, and weakness encourage direct search for the G1306E mutation, a hotspot for de-novo mutations." | 1.46 | Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life. ( Bertini, E; D'Amico, A; Jurkat-Rott, K; Lehmann-Horn, F; Lomonaco, M; Merlini, L; Nelson, KR; Philippi, H; Siciliano, G; Spaans, F, 2017) |
| "Supraventricular tachycardia is uncommon in pregnancy." | 1.40 | Management of labour and delivery in a woman with refractory supraventricular tachycardia. ( Dennis, AT; Gerstman, MD, 2014) |
| " The most frequently reported extracardiac adverse experiences were dizziness (30%) and visual disturbances (28%), often occurring in tandem." | 1.27 | Extracardiac adverse effects of flecainide. ( Gentzkow, GD; Sullivan, JY, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moureau, G | 1 |
| Zarrouk, E | 1 |
| Hoton, D | 1 |
| Saint-Marcoux, F | 1 |
| Boland, L | 1 |
| Haufroid, V | 1 |
| Hantson, P | 1 |
| Lehmann-Horn, F | 1 |
| D'Amico, A | 1 |
| Bertini, E | 1 |
| Lomonaco, M | 1 |
| Merlini, L | 1 |
| Nelson, KR | 1 |
| Philippi, H | 1 |
| Siciliano, G | 1 |
| Spaans, F | 1 |
| Jurkat-Rott, K | 1 |
| Dennis, AT | 1 |
| Gerstman, MD | 1 |
| Lip, GY | 1 |
| Fauchier, L | 1 |
| Freedman, SB | 1 |
| Van Gelder, I | 1 |
| Natale, A | 1 |
| Gianni, C | 1 |
| Nattel, S | 1 |
| Potpara, T | 1 |
| Rienstra, M | 1 |
| Tse, HF | 1 |
| Lane, DA | 1 |
| Gentzkow, GD | 1 |
| Sullivan, JY | 1 |
1 review available for flecainide and Dyspnea
| Article | Year |
|---|---|
Atrial fibrillation.
Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun | 2016 |
4 other studies available for flecainide and Dyspnea
| Article | Year |
|---|---|
Flecainide-induced pneumonitis: a case report.
Topics: Biopsy; Cryptogenic Organizing Pneumonia; Dyspnea; Female; Flecainide; Humans; Lung; Middle Aged; Pn | 2022 |
Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life.
Topics: Action Potentials; Adolescent; Adult; Age Factors; Child; Child, Preschool; Dyspnea; Exercise; Femal | 2017 |
Management of labour and delivery in a woman with refractory supraventricular tachycardia.
Topics: Adult; Amides; Amnion; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia, Epidural; Anes | 2014 |
Extracardiac adverse effects of flecainide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dizziness; Dyspnea; Flecainide; Headache; Humans; Naus | 1984 |